Related Experiment Video
Updated: Nov 17, 2025

Transverse Aortic Constriction in Mice
Published on: April 21, 2010
The Nobel Prize in Physiology or Medicine-2020
11st Department of Surgery and Interventional Gastroenterology, Semmelweis University, Budapest, Hungary.
Insights
The discovery of the Hepatitis C virus (HCV) led to blood screening and effective antiviral treatments. This breakthrough enables a 95% cure rate, supporting the WHO
Area of Science:
- Virology
- Hepatology
- Infectious Diseases
Background:
- The Hepatitis C virus (HCV) causes chronic liver disease in 80% of infected individuals.
- HCV infection is a leading cause of cirrhosis, liver failure, and hepatocellular carcinoma.
Purpose of the Study:
- To highlight the significance of the 2020 Nobel Prize in Physiology or Medicine.
- To underscore the impact of discovering the Hepatitis C virus.
Main Methods:
- Isolation of the Hepatitis C virus.
- Development of diagnostic screening for blood and blood products.
- Advancement of direct-acting antiviral agents for treatment.
Main Results:
- Enabled effective screening of blood donations, significantly reducing transmission.
- Achieved a cure rate exceeding 95% for infected individuals.
- Minimized side effects associated with antiviral therapies.
Conclusions:
- The discovery of HCV has revolutionized patient care and public health strategies.
- Current treatments offer a high cure rate, aligning with the WHO's goal to eliminate viral hepatitis by 2030.
Abstract:
At the time of COVID-19 coronavirus pandemia, the Nobel Prize of Physiology or Medicine 2020 was awarded jointly to three researchers Harvey J. Alter, Charles M. Rice, and Michael Houghton for the discovery of Hepatitis C virus. Their works contributed to the isolation of the blood-borne virus, causing chronic hepatitis in 80% of infected person, resulting in cirrhosis, and in elevated risk of liver failure and hepatocellular carcinoma formation. Their results created the basis of HCV screening of blood, and blood products, achieving more than 95% cure of infected people without nearly side effects with direct-acting antiviral agents, supporting the goal of the WHO targeting the elimination of viral hepatitis by 2030.
Related Concept Videos
Mechanically-gated Ion Channels
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
EPS and iPS Cells in Disease Research
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Nitric Oxide Signaling Pathway
Pathophysiology of Cardiac Performance

